Skip to main content
×
Home
    • Aa
    • Aa
  • Access
  • Cited by 15
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Nicod, Elena and Kanavos, Panos 2012. Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions. Health Policy, Vol. 108, Issue. 2-3, p. 167.


    Garber, Alan M. and Sculpher, Mark J. 2011.


    Martinalbo, J. Bowen, D. Camarero, J. Chapelin, M. Démolis, P. Foggi, P. Jonsson, B. Llinares, J. Moreau, A. O'Connor, D. Oliveira, J. Vamvakas, S. and Pignatti, F. 2016. Early market access of cancer drugs in the EU. Annals of Oncology, Vol. 27, Issue. 1, p. 96.


    Vogler, Sabine Leopold, Christine Zimmermann, Nina Habl, Claudia and de Joncheere, Kees 2014. The Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative—Experiences from engaging with pharmaceutical policy makers. Health Policy and Technology, Vol. 3, Issue. 2, p. 139.


    Ritrovato, Matteo Faggiano, Francesco C. Tedesco, Giorgia and Derrico, Pietro 2015. Decision-Oriented Health Technology Assessment: One Step Forward in Supporting the Decision-Making Process in Hospitals. Value in Health, Vol. 18, Issue. 4, p. 505.


    Zelei, Tamás Molnár, Mária J. Szegedi, Márta and Kaló, Zoltán 2016. Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries. Orphanet Journal of Rare Diseases, Vol. 11, Issue. 1,


    Legido-Quigley, Helena Panteli, Dimitra Brusamento, Serena Knai, Cécile Saliba, Vanessa Turk, Eva Solé, Meritxell Augustin, Uta Car, Josip McKee, Martin and Busse, Reinhard 2012. Clinical guidelines in the European Union: Mapping the regulatory basis, development, quality control, implementation and evaluation across member states. Health Policy, Vol. 107, Issue. 2-3, p. 146.


    Xie, Feng Bowen, James M Sutherland, Simone C Burke, Natasha Blackhouse, Gord Tarride, Jean-Eric O’Reilly, Daria and Goeree, Ron 2011. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Review of Pharmacoeconomics & Outcomes Research, Vol. 11, Issue. 5, p. 513.


    Berntgen, Michael Gourvil, Anne Pavlovic, Mira Goettsch, Wim Eichler, Hans-Georg and Kristensen, Finn Børlum 2014. Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment. Value in Health, Vol. 17, Issue. 5, p. 634.


    Reed, Shelby D. Eapen, Zubin J. and Schulman, Kevin A. 2011. End Point Selection in Acute Decompensated Heart Failure Clinical Trials: Economic End Points. Heart Failure Clinics, Vol. 7, Issue. 4, p. 529.


    Ormstad, Sari Susanna and Isojärvi, Jaana 2010. Information retrieval for health technology assessment: Standardization of search methods. International Journal of Technology Assessment in Health Care, Vol. 26, Issue. 04, p. 359.


    van Voorn, George A. K. Vemer, Pepijn Hamerlijnck, Dominique Ramos, Isaac Corro Teunissen, Geertruida J. Al, Maiwenn and Feenstra, Talitha L. 2016. The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling. Applied Health Economics and Health Policy, Vol. 14, Issue. 2, p. 129.


    Frederix, Gerardus W. J. Haji Ali Afzali, Hossein Dasbach, Erik J. and Ward, Robyn L. 2015. Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions. PharmacoEconomics, Vol. 33, Issue. 8, p. 777.


    Panteli, Dimitra Eckhardt, Helene Nolting, Alexandra Busse, Reinhard and Kulig, Michael 2015. From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries. Health Research Policy and Systems, Vol. 13, Issue. 1,


    Cornel, Martina C Rigter, Tessel Weinreich, Stephanie S Burgard, Peter Hoffmann, Georg F Lindner, Martin Gerard Loeber, J Rupp, Kathrin Taruscio, Domenica and Vittozzi, Luciano 2014. A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document. European Journal of Human Genetics, Vol. 22, Issue. 1, p. 12.


    ×

European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment

  • Finn Børlum Kristensen (a1), Marjukka Mäkelä (a2), Susanna Allgurin Neikter (a3), Nina Rehnqvist (a4), Lise Lund Håheim (a5), Berit Mørland (a5), Ruairidh Milne (a6), Camilla Palmhøj Nielsen (a7), Reinhard Busse (a8), Sun Hae Lee-Robin (a9), Claudia Wild (a10), Mireia Espallargues (a11) and Julia Chamova (a12)
  • DOI: http://dx.doi.org/10.1017/S0266462309990754
  • Published online: 23 December 2009
Abstract

Objectives: The European network on Health Technology Assessment (EUnetHTA) aimed to produce tangible and practical results to be used in the various phases of health technology assessment and to establish a framework and processes to support this. This article presents the background, objectives, and organization of EUnetHTA, which involved a total of sixty-four partner organizations.

Methods: Establishing an effective and sustainable structure for a transnational network involved many managerial, policy, and methodological tools, according to the objective of each task or Work Package. Transparency in organization, financial transactions, and decision making was a key principle in the management of the Project as was the commitment to appropriately involve stakeholders.

Results: EUnetHTA activities resulted in a clear management and governance structure, efficient partnership, and transnational cooperation. The Project developed a model for sustainable continuation of the EUnetHTA Collaboration.

Conclusions: The EUnetHTA Project achieved its goals by producing a suite of practical tools, a strong network, and plans for continuing the work in a sustainable EUnetHTA Collaboration that facilitates and promotes the use of HTA at national and regional levels. Responsiveness to political developments in Europe should be balanced with maintaining a high level of ambition to promote independent, evidence-based information and well-tested tools for best practice based on a strong network of HTA institutions.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment
      Your Kindle email address
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment
      Available formats
      ×
Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.


4.HD Banta , W Oortwijn . Conclusion: Health technology assessment and health care in the European Union. Int J Technol Assess Health Care. 2000;16:626635.

22.FB Kristensen , K Lampe , DL Chase , Practical tools and methods for health technology assessment in Europe: Structures, methodologies, and tools developed by the European network for Health Technology Assessment, EUnetHTA. Int J Technol Assess Health Care. 2009;25 (Suppl 2):1-8.

25.C Palmhøj Nielsen , S Wadmann Lauritsen , FB Kristensen , et al. Involving stakeholders and developing a policy for stakeholder involvement in the European network for Health Technology Assessment, EUnetHTA. Int J Technol Assess Health Care. 2009;25 (Suppl 2):8491.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
UNKNOWN
Supplementary Materials

Kristiansen supplementary material
Supplementary table and list

 Unknown (352 KB)
352 KB